Company

Synplogen Co., Ltd.

Synplogen Co., Ltd. is a Kobe-based biotech specializing in long-chain DNA synthesis and viral vectors for gene therapy.

About

Founded in 2017 and headquartered in Kobe, Japan, Synplogen Co., Ltd. develops DNA synthesis methods such as OGAB and Combi-OGAB for making long DNA sequences, and offers artificial gene synthesis and DNA library construction. It also supplies viral vectors for gene therapy through its Biofoundry services, selling to research institutions, pharmaceutical companies and biotech firms. In March 2023 the company raised JPY 922 million in Series C funding from Sojitz Corporation.

2Funding rounds

1Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in